Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viropharma Inc (VPHM) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viropharma Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 946840.
Total stock buying since 2010: $49,157,849.
Total stock sales since 2010: $53,520,016.
Total stock option exercises since 2010: $23,685,621.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 0 | $0 | 0 | $0 | 494,886 | $4,977,322 |
| 2013 | 0 | $0 | 0 | $0 | 1,035,925 | $10,399,907 |
| 2012 | 2,500 | $62,675 | 735,267 | $20,785,973 | 729,448 | $4,763,987 |
| 2011 | 2,545,820 | $48,850,874 | 414,194 | $9,049,817 | 447,999 | $2,954,663 |
| 2010 | 20,000 | $244,300 | 1,862,551 | $23,684,226 | 88,359 | $589,742 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-01 | 0 | $0 | 0 | $0 | 494,886 | $4,977,322 |
| 2013-12 | 0 | $0 | 0 | $0 | 1,025,925 | $10,382,207 |
| 2013-02 | 0 | $0 | 0 | $0 | 10,000 | $17,700 |
| 2012-12 | 2,500 | $62,675 | 180,499 | $4,326,534 | 120,499 | $725,336 |
| 2012-11 | 0 | $0 | 163,418 | $4,029,094 | 171,418 | $1,099,303 |
| 2012-06 | 0 | $0 | 10,000 | $200,430 | 10,000 | $34,200 |
| 2012-03 | 0 | $0 | 381,350 | $12,229,915 | 417,531 | $2,626,048 |
| 2012-01 | 0 | $0 | 0 | $0 | 10,000 | $279,100 |
| 2011-12 | 400,666 | $10,933,373 | 100,000 | $2,444,980 | 133,805 | $1,016,251 |
| 2011-11 | 0 | $0 | 200,058 | $4,429,574 | 200,058 | $1,100,820 |
| 2011-10 | 742,183 | $13,191,018 | 20,495 | $418,548 | 20,495 | $64,354 |
| 2011-09 | 1,113,810 | $19,955,010 | 0 | $0 | 0 | $0 |
| 2011-08 | 289,161 | $4,771,473 | 20,000 | $400,000 | 20,000 | $400,000 |
| 2011-03 | 0 | $0 | 73,641 | $1,356,715 | 73,641 | $373,238 |
| 2010-12 | 0 | $0 | 19,500 | $323,857 | 37,000 | $335,848 |
| 2010-11 | 0 | $0 | 6,359 | $108,357 | 6,359 | $18,695 |
| 2010-09 | 0 | $0 | 30,000 | $397,926 | 30,000 | $55,199 |
| 2010-05 | 20,000 | $244,300 | 1,806,692 | $22,854,086 | 15,000 | $180,000 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-01-21 | Doyle Thomas F (VP Strategic Initiatives) | Option Ex | 59,645 | 11.28 | 672,795 |
| 2014-01-17 | Wolf John Peter Iii (VP, General Counsel) | Option Ex | 69,785 | 12.01 | 838,117 |
| 2014-01-17 | Milano Vincent (President and CEO) | Option Ex | 79,126 | 10.38 | 821,011 |
| 2014-01-08 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 45,837 | 10.55 | 483,580 |
| 2014-01-08 | Rowland Charles A Jr (VP, Chief Financial Officer) | Option Ex | 28,753 | 10.06 | 289,197 |
| 2014-01-08 | Soland Daniel B (VP, Chief Operating Officer) | Option Ex | 19,289 | 9.56 | 184,499 |
| 2014-01-08 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 142,142 | 10.63 | 1,510,827 |
| 2014-01-07 | Brooke Paul A (Director) | Option Ex | 10,000 | 3.42 | 34,200 |
| 2014-01-06 | Milano Vincent (President and CEO) | Option Ex | 40,309 | 3.55 | 143,096 |
| 2013-12-27 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 4,675 | 5.91 | 27,629 |
| 2013-12-27 | Rowland Charles A Jr (VP, Chief Financial Officer) | Option Ex | 4,540 | 5.91 | 26,831 |
| 2013-12-27 | Soland Daniel B (VP, Chief Operating Officer) | Option Ex | 11,500 | 5.91 | 67,965 |
| 2013-12-18 | Fletcher Robert C. (V.P., Business Development) | Option Ex | 88,972 | 12.12 | 1,077,895 |
| 2013-12-18 | Wolf John Peter Iii (VP, General Counsel) | Option Ex | 100,227 | 12.78 | 1,280,700 |
| 2013-12-18 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 49,911 | 8.24 | 411,416 |
| 2013-12-18 | Rowland Charles A Jr (VP, Chief Financial Officer) | Option Ex | 49,006 | 8.91 | 436,643 |
| 2013-12-18 | Soland Daniel B (VP, Chief Operating Officer) | Option Ex | 120,784 | 7.38 | 891,989 |
| 2013-12-18 | Milano Vincent (President and CEO) | Option Ex | 586,310 | 10.45 | 6,126,939 |
| 2013-12-18 | Dougherty Michael R (Director) | Option Ex | 10,000 | 3.42 | 34,200 |
| 2013-02-20 | Brooke Paul A (Director) | Option Ex | 10,000 | 1.77 | 17,700 |
| 2012-12-27 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 10,000 | 1.84 | 18,400 |
| 2012-12-24 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 17,500 | 22.53 | 394,310 |
| 2012-12-24 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 17,500 | 1.84 | 32,200 |
| 2012-12-13 | Brooke Paul A (Director) | Sale | 60,000 | 23.87 | 1,431,960 |
| 2012-12-10 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 74,999 | 24.07 | 1,805,000 |
| 2012-12-10 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 74,999 | 8.24 | 618,216 |
| 2012-12-03 | Wolf John Peter Iii (VP, General Counsel) | Sale | 18,000 | 24.85 | 447,264 |
| 2012-12-03 | Wolf John Peter Iii (VP, General Counsel) | Option Ex | 18,000 | 3.14 | 56,520 |
| 2012-12-03 | Claypool William D Md (Director) | Sale | 10,000 | 24.80 | 248,000 |
| 2012-12-03 | Dougherty Michael R (Director) | Buy | 2,500 | 25.07 | 62,675 |
| 2012-11-30 | Glaser Robert (Director) | Sale | 30,000 | 24.78 | 743,370 |
| 2012-11-30 | Glaser Robert (Director) | Option Ex | 30,000 | 11.57 | 347,250 |
| 2012-11-28 | Claypool William D Md (Director) | Sale | 17,500 | 24.22 | 423,885 |
| 2012-11-28 | Claypool William D Md (Director) | Option Ex | 17,500 | 8.22 | 143,850 |
| 2012-11-28 | Milano Vincent (President and CEO) | Option Ex | 18,000 | 3.55 | 63,900 |
| 2012-11-13 | Claypool William D Md (Director) | Sale | 22,500 | 24.93 | 560,812 |
| 2012-11-13 | Claypool William D Md (Director) | Option Ex | 22,500 | 7.42 | 166,837 |
| 2012-11-08 | Milano Vincent (President and CEO) | Sale | 83,418 | 24.54 | 2,047,327 |
| 2012-11-08 | Milano Vincent (President and CEO) | Option Ex | 83,418 | 4.53 | 377,466 |
| 2012-11-02 | Claypool William D Md (Director) | Sale | 10,000 | 25.37 | 253,700 |
| 2012-06-11 | Claypool William D Md (Director) | Sale | 10,000 | 20.04 | 200,430 |
| 2012-06-11 | Claypool William D Md (Director) | Option Ex | 10,000 | 3.42 | 34,200 |
| 2012-03-23 | Pietrusko Robert (VP, Regulatory & Quality) | Sale | 20,000 | 30.00 | 600,000 |
| 2012-03-23 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 20,000 | 8.86 | 177,200 |
| 2012-03-09 | Fletcher Robert C. (V.P., Business Development) | Sale | 32,000 | 29.66 | 948,960 |
| 2012-03-09 | Fletcher Robert C. (V.P., Business Development) | Option Ex | 32,000 | 3.19 | 102,080 |
| 2012-03-09 | Morris Richard Steven (Chief Accounting Officer) | Sale | 1,300 | 29.71 | 38,617 |
| 2012-03-09 | Morris Richard Steven (Chief Accounting Officer) | Option Ex | 1,300 | 7.05 | 9,165 |
| 2012-03-09 | Soland Daniel B (VP, Chief Operating Officer) | Option Ex | 48,293 | 12.88 | 622,158 |
| 2012-03-07 | Rowland Charles A Jr (VP, Chief Financial Officer) | Option Ex | 30,638 | 12.73 | 390,021 |
| 2012-03-05 | Morris Richard Steven (Chief Accounting Officer) | Sale | 5,300 | 33.01 | 174,953 |
| 2012-03-05 | Morris Richard Steven (Chief Accounting Officer) | Option Ex | 5,300 | 6.48 | 34,344 |
| 2012-03-05 | Doyle Thomas F (VP Strategic Initiatives) | Sale | 210,000 | 32.48 | 6,820,169 |
| 2012-03-05 | Doyle Thomas F (VP Strategic Initiatives) | Option Ex | 210,000 | 3.18 | 667,380 |
| 2012-03-01 | Rowland Charles A Jr (VP, Chief Financial Officer) | Sale | 82,750 | 32.12 | 2,657,516 |
| 2012-03-01 | Rowland Charles A Jr (VP, Chief Financial Officer) | Option Ex | 70,000 | 8.91 | 623,700 |
| 2012-03-01 | Soland Daniel B (VP, Chief Operating Officer) | Sale | 30,000 | 32.99 | 989,700 |
| 2012-01-04 | Milano Vincent (President and CEO) | Option Ex | 10,000 | 27.91 | 279,100 |
| 2011-12-29 | Fletcher Robert C. (V.P., Business Development) | Option Ex | 1,300 | 22.99 | 29,886 |
| 2011-12-23 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 17,500 | 1.84 | 32,200 |
| 2011-12-14 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 50,000 | 25.34 | 1,266,750 |
| 2011-12-14 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 50,000 | 8.71 | 435,500 |
| 2011-12-14 | Baker Felix (10% Owner) | Buy | 58,394 | 27.29 | 1,593,455 |
| 2011-12-14 | Baker Julian (10% Owner) | Buy | 291,706 | 27.29 | 7,960,073 |
| 2011-12-13 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 22,330 | 23.50 | 524,755 |
| 2011-12-13 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 22,330 | 7.05 | 157,426 |
| 2011-12-12 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 17,670 | 23.50 | 415,315 |
| 2011-12-12 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 17,670 | 7.05 | 124,573 |
| 2011-12-05 | Milano Vincent (President and CEO) | Option Ex | 15,005 | 2.34 | 35,066 |
| 2011-12-01 | Doyle Thomas F (VP Strategic Initiatives) | Sale | 10,000 | 23.82 | 238,160 |
| 2011-12-01 | Doyle Thomas F (VP Strategic Initiatives) | Option Ex | 10,000 | 20.16 | 201,600 |
| 2011-11-30 | Pietrusko Robert (VP, Regulatory & Quality) | Sale | 20,000 | 24.00 | 480,000 |
| 2011-11-30 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 20,000 | 9.99 | 199,800 |
| 2011-11-28 | Pietrusko Robert (VP, Regulatory & Quality) | Sale | 19,000 | 23.00 | 437,000 |
| 2011-11-28 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 19,000 | 9.99 | 189,810 |
| 2011-11-28 | Glaser Robert (Director) | Sale | 5,000 | 23.00 | 115,000 |
| 2011-11-28 | Glaser Robert (Director) | Option Ex | 5,000 | 3.00 | 15,000 |
| 2011-11-23 | Pietrusko Robert (VP, Regulatory & Quality) | Sale | 1,000 | 23.00 | 23,000 |
| 2011-11-23 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 1,000 | 9.99 | 9,990 |
| 2011-11-21 | Milano Vincent (President and CEO) | Sale | 76,687 | 22.53 | 1,727,451 |
| 2011-11-21 | Milano Vincent (President and CEO) | Option Ex | 76,687 | 3.19 | 244,631 |
| 2011-11-16 | Morris Richard Steven (Chief Accounting Officer) | Sale | 2,000 | 22.59 | 45,180 |
| 2011-11-16 | Morris Richard Steven (Chief Accounting Officer) | Option Ex | 2,000 | 20.28 | 40,560 |
| 2011-11-14 | Pietrusko Robert (VP, Regulatory & Quality) | Sale | 20,000 | 22.00 | 440,000 |
| 2011-11-14 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 20,000 | 8.86 | 177,200 |
| 2011-11-07 | Wolf John Peter Iii (VP, General Counsel) | Sale | 12,250 | 21.08 | 258,193 |
| 2011-11-07 | Wolf John Peter Iii (VP, General Counsel) | Option Ex | 12,250 | 2.44 | 29,890 |
| 2011-11-07 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 20,000 | 21.00 | 420,100 |
| 2011-11-07 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 20,000 | 5.91 | 118,200 |
| 2011-11-01 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 24,121 | 20.05 | 483,650 |
| 2011-11-01 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 24,121 | 3.14 | 75,739 |
| 2011-10-31 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 20,495 | 20.42 | 418,548 |
| 2011-10-31 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 20,495 | 3.14 | 64,354 |
| 2011-10-05 | Baker Felix (10% Owner) | Buy | 22,295 | 18.18 | 405,389 |
| 2011-10-05 | Baker Julian (10% Owner) | Buy | 145,763 | 18.18 | 2,650,408 |
| 2011-10-04 | Baker Felix (10% Owner) | Buy | 4,416 | 17.48 | 77,173 |
| 2011-10-04 | Baker Julian (10% Owner) | Buy | 45,584 | 17.48 | 796,625 |
| 2011-10-03 | Baker Julian (10% Owner) | Buy | 516,203 | 17.66 | 9,118,725 |
| 2011-09-30 | Baker Felix (10% Owner) | Buy | 25,222 | 18.14 | 457,425 |
| 2011-09-30 | Baker Julian (10% Owner) | Buy | 131,978 | 18.14 | 2,393,553 |
| 2011-09-29 | Baker Felix (10% Owner) | Buy | 42,502 | 17.98 | 764,313 |
| 2011-09-29 | Baker Julian (10% Owner) | Buy | 249,915 | 17.98 | 4,494,221 |
| 2011-09-26 | Baker Felix (10% Owner) | Buy | 33,068 | 18.13 | 599,455 |
| 2011-09-26 | Baker Julian (10% Owner) | Buy | 159,641 | 18.13 | 2,893,972 |
| 2011-09-23 | Baker Felix (10% Owner) | Buy | 45,661 | 17.70 | 808,245 |
| 2011-09-23 | Baker Julian (10% Owner) | Buy | 224,769 | 17.70 | 3,978,636 |
| 2011-09-22 | Baker Felix (10% Owner) | Buy | 11,849 | 17.43 | 206,479 |
| 2011-09-22 | Baker Julian (10% Owner) | Buy | 63,151 | 17.43 | 1,100,469 |
| 2011-08-31 | Pietrusko Robert (VP, Regulatory & Quality) | Sale | 20,000 | 20.00 | 400,000 |
| 2011-08-31 | Pietrusko Robert (VP, Regulatory & Quality) | Option Ex | 20,000 | 20.00 | 400,000 |
| 2011-08-23 | Baker Felix (10% Owner) | Buy | 5,971 | 16.97 | 101,350 |
| 2011-08-23 | Baker Julian (10% Owner) | Buy | 32,704 | 16.97 | 555,117 |
| 2011-08-10 | Baker Felix (10% Owner) | Buy | 5,934 | 16.43 | 97,477 |
| 2011-08-10 | Baker Julian (10% Owner) | Buy | 244,049 | 16.43 | 4,008,992 |
| 2011-03-14 | Rowland Charles A Jr (VP, Chief Financial Officer) | Sale | 35,000 | 18.56 | 649,740 |
| 2011-03-14 | Rowland Charles A Jr (VP, Chief Financial Officer) | Option Ex | 35,000 | 7.38 | 258,475 |
| 2011-03-03 | Claypool William D Md (Director) | Sale | 38,641 | 18.30 | 706,975 |
| 2011-03-03 | Claypool William D Md (Director) | Option Ex | 38,641 | 2.97 | 114,763 |
| 2010-12-31 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 2,500 | 1.84 | 4,600 |
| 2010-12-14 | Glaser Robert (Director) | Sale | 5,000 | 16.75 | 83,750 |
| 2010-12-13 | Doyle Thomas F (VP Strategic Initiatives) | Option Ex | 10,000 | 14.12 | 141,250 |
| 2010-12-13 | Milano Vincent (President and CEO) | Option Ex | 10,000 | 14.12 | 141,250 |
| 2010-12-09 | Morris Richard Steven (Chief Accounting Officer) | Sale | 13,300 | 16.56 | 220,247 |
| 2010-12-09 | Morris Richard Steven (Chief Accounting Officer) | Option Ex | 13,300 | 3.35 | 44,488 |
| 2010-12-08 | Morris Richard Steven (Chief Accounting Officer) | Sale | 1,200 | 16.55 | 19,860 |
| 2010-12-08 | Morris Richard Steven (Chief Accounting Officer) | Option Ex | 1,200 | 3.55 | 4,260 |
| 2010-11-09 | Claypool William D Md (Director) | Sale | 6,359 | 17.04 | 108,357 |
| 2010-11-09 | Claypool William D Md (Director) | Option Ex | 6,359 | 2.94 | 18,695 |
| 2010-09-13 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 5,060 | 13.28 | 67,171 |
| 2010-09-13 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 5,060 | 1.84 | 9,310 |
| 2010-09-10 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 7,900 | 13.26 | 104,754 |
| 2010-09-10 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 7,900 | 1.84 | 14,536 |
| 2010-09-09 | Broom Colin Md (VP & Chief Scientific Officer) | Sale | 17,040 | 13.26 | 226,001 |
| 2010-09-09 | Broom Colin Md (VP & Chief Scientific Officer) | Option Ex | 17,040 | 1.84 | 31,353 |
| 2010-05-27 | Glaser Robert (Director) | Sale | 10,000 | 12.50 | 125,000 |
| 2010-05-27 | Glaser Robert (Director) | Option Ex | 10,000 | 12.00 | 120,000 |
| 2010-05-10 | Baker Felix (10% Owner) | Sale | 515,590 | 12.70 | 6,548,508 |
| 2010-05-07 | Soland Daniel B (VP, Chief Operating Officer) | Buy | 10,000 | 11.91 | 119,100 |
| 2010-05-07 | Baker Felix (10% Owner) | Sale | 109,044 | 12.46 | 1,358,469 |
| 2010-05-06 | Soland Daniel B (VP, Chief Operating Officer) | Buy | 10,000 | 12.52 | 125,200 |
| 2010-05-06 | Baker Felix (10% Owner) | Sale | 319,272 | 12.64 | 4,034,320 |
Insider trading activities including stock purchases, stock sales, and option exercises of VPHM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viropharma Inc (symbol VPHM, CIK number 946840) see the Securities and Exchange Commission (SEC) website.